mesomelic dysplasia, Kantaputra type
diseaseOn this page
Also known as Kantaputra mesomelic dysplasiaMDKmesomelic dysplasia Kantaputra typemesomelic dysplasia Thai typemesomelic dysplasia with ankle carpal and tarsal synostosismesomelic dysplasia, Thai typeMMDK
Summary
mesomelic dysplasia, Kantaputra type (MONDO:0007977) is a disease. A subtype of mesomelic dysplasia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 15
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 5 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
15 HPO clinical features (Orphanet curated; top 15 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0002991 | Abnormal fibula morphology | Very frequent (80-99%) |
| HP:0003027 | Mesomelia | Very frequent (80-99%) |
| HP:0003028 | Abnormality of the ankles | Very frequent (80-99%) |
| HP:0004322 | Short stature | Very frequent (80-99%) |
| HP:0005009 | Dumbbell-shaped humerus | Very frequent (80-99%) |
| HP:0008368 | Tarsal synostosis | Very frequent (80-99%) |
| HP:0100490 | Camptodactyly of finger | Very frequent (80-99%) |
| HP:0031095 | Abnormal humerus morphology | Very frequent (80-99%) |
| HP:0004209 | Clinodactyly of the 5th finger | Frequent (30-79%) |
| HP:0005048 | Synostosis of carpal bones | Frequent (30-79%) |
| HP:0009465 | Ulnar deviation of finger | Frequent (30-79%) |
| HP:0000772 | Abnormal rib morphology | Occasional (5-29%) |
| HP:0001883 | Talipes | Occasional (5-29%) |
| HP:0002967 | Cubitus valgus | Occasional (5-29%) |
| HP:0003422 | Vertebral segmentation defect | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | mesomelic dysplasia, Kantaputra type |
| Mondo ID | MONDO:0007977 |
| MeSH | C535547 |
| OMIM | 156232 |
| Orphanet | 1836 |
| SNOMED CT | 719397009 |
| UMLS | C1835009 |
| MedGen | 331880 |
| GARD | 0003074 |
| Is cancer (heuristic) | no |
Also known as: Kantaputra mesomelic dysplasia · MDK · mesomelic dysplasia Kantaputra type · mesomelic dysplasia Thai type · mesomelic dysplasia with ankle carpal and tarsal synostosis · mesomelic dysplasia, Kantaputra type · mesomelic dysplasia, Thai type · MMDK
Disease family
An umbrella term covering 1 Mondo subtype.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › skeletal system disorder › bone disorder › bone development disease › osteochondrodysplasia › mesomelic dysplasia › mesomelic dysplasia, Kantaputra type
Related subtypes (5): mesomelic dwarfism, Nievergelt type, mesomelic dwarfism, Reinhardt-Pfeiffer type, upper limb mesomelic dysplasia, Langer mesomelic dysplasia, mesomelic dysplasia, Savarirayan type
Subtypes (1): chromosome 2q31.1 duplication syndrome
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.